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M. Ibáñez, E. Gracia-Lor, J. V. Sancho and F. Hernández 
Research Institute for Pesticides and Water, University Jaume, Castellón, Spain 
 
ABSTRACT 
Pharmaceuticals are emerging contaminants of increasing concern because of their 
presence in the aquatic environment and potential to reach drinking-water sources. After human 
and/or veterinary consumption, pharmaceuticals can be excreted in unchanged form, as the 
parent compound, and/or as free or conjugated metabolites. Determination of most 
pharmaceuticals and metabolites in the environment is commonly made by liquid 
chromatography (LC) coupled to mass spectrometry (MS). LC coupled to tandem MS is the 
technique of choice nowadays in this field. The acquisition of two selected reaction monitoring 
(SRM) transitions together with the retention time is the most widely accepted criterion for a 
safe quantification and confirmation assay. However, scarce attention is normally paid to the 
selectivity of the selected transitions as well as to the chromatographic separation. In this work, 
the importance of full spectrum acquisition high-resolution MS data using a hybrid quadrupole 
time-of-flight analyser and/or a suitable chromatographic separation (to reduce the possibility of 
co-eluting interferences) is highlighted when investigating pharmaceutical metabolites that 
share common fragment ions. For this purpose, the analytical challenge associated to the 
determination of metabolites of the widely used analgesic dipyrone (also known as metamizol) 
in urban wastewater is discussed. Examples are given on the possibilities of reporting false 
positives of dypirone metabolites by LC-MS/MS under SRM mode due to a wrong assignment 
of identity of the compounds detected.  
Keywords 
Dipyrone; Pharmaceutical metabolites; Ultrahigh pressure liquid chromatography; Time-
of-flight mass spectrometry; MSE; Urban wastewater; False positives. 
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1. Introduction 
The presence of pharmaceuticals in the environment is a matter of concern because of 
their wide consumption and potential negative effect on the water quality and living 
organisms.[1,2] After human and/or veterinary consumption, pharmaceuticals are excreted in 
unchanged form, as the parent compound, and also as free and/or conjugates metabolites. 
Once pharmaceuticals reach the aquatic environment, both the parent compound and 
metabolites can suffer different transformation processes, mainly photodegradation and 
hydrolysis, producing a variety of transformation products in water. 
Most recent methods for the determination of pharmaceuticals in the environment are 
based on the use of liquid chromatography coupled to mass spectrometry (LC-MS), and 
particularly on LC-tandem mass spectrometry (LC-MS/MS) using triple quadrupole (QqQ) 
analyser.[3,4] The usual approach has been the acquisition of two transitions in LC-MS/MS 
methods, which fulfills existing guidelines.[5,6] Confirmation of positive findings is based on the 
accomplishment of ion ratio and retention time, which must fit the limits established by current 
guideliness. Under these circumstances, not much attention is paid to the chromatographic 
separation and/or transitions selectivity, assuming that other compounds present in the sample 
will not fulfil these criteria. 
The satisfactory sensitivity in full spectrum acquisition mode, high resolution (HR), exact 
mass measurements and MS/MS capabilities of hybrid quadrupole time-of-flight (QTOF) mass 
spectrometry make of this technique a powerful analytical tool for the identification and 
confirmation of organic contaminants. Moreover, and opposed to analytical methods based on 
selected ion monitoring or selected reaction monitoring (SRM), accurate-mass full-spectrum 
data generated by LC-(Q)TOF MS remain available over time. This allows investigating any 
other compound in addition to target analytes, provided such compound has passed the sample 
preparation, chromatographic separation and ionization process with sufficient efficiency. This 
fact clearly represents an important advantage of HRMS for wide scope screening of organic 
contaminants.[7-9] In the last years, there has been a growing trend on using TOF MS for 
screening and confirmation of pharmaceuticals in environmental samples.[4, 10-12] However, it has 
been scarcely used to investigate pharmaceutical metabolites in the environment.[13] 
Dipyrone (DIP, also known as metamizol) is a non-steroidal anti-inflammatory drug, 
commonly used to treat severe pain associated with colic, cancer and migranes.[14] It is 
marketed under various trade names, including Conmel®, Neo-Melubrina®, Magnopyrol®, 
Prodolina F®, Analgin®, Nolotil® and Novalgin®. Immediately after its introduction in 1922, the 
use of DIP was linked to serious toxic effects, such as dose-independent teratogenicity, 
increased bleeding times and a potentially fatal agranulocytosis.[15] While the use of DIP has 
been banned in USA, Canada or UK, in many Western European countries (e.g. Germany, Italy 
or Spain), it is still one of the most consumed pharmaceuticals.[16] DIP is considered a pro-drug. 
After oral intake, it is rapidly hydrolyzed to 4-methylaminoantipyrine (4-MAA), which is absorbed 
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and bio-transformed by enzymatic reactions. In the liver, 4-MAA is metabolized to 4-
aminoantipyrine (4-AA) via demethylation and further acetylated to 4-acetylaminoantipyrine (4-
AAA). Another metabolite, 4-formylaminoantipyrine (4-FAA), is generated by oxidation of the 
methyl group.[16] The presence of these DIP metabolites has been reported in sewage treatment 
plant effluents [12, 17] and in surface water.[17] 
In a previous work,[18] the presence of 4-amino antipyrine (4-AA) in urban wastewater 
was reported based on the monitoring of two SRM transitions using a LC-MS/MS method. A 
slight shift in retention time together with the presence of clear shoulders in the 
chromatographic peak was observed. However, both retention time and ion ratio deviations as 
regards the reference standard were within the tolerances established. Despite all requirements 
established by current guidelines were satisfied, reasonable doubts about a false positive due to 
unresolved interferences might be hypothesized. The goal of this paper is to point out the 
benefits of using full spectrum acquisition HRMS, and the need of applying efficient 
chromatographic separation in some particular complex situations, as for example when 
investigating pharmaceutical metabolites. For this purpose, the analytical challenge associated 
to the determination of DIP metabolites in urban wastewater is studied in depth making use of 
QTOF and QqQ analysers both coupled to UPLC. 
 
 
2. Experimental 
2.1. Reagents and chemicals 
Reference standards (purity higher than 93%) of 4-AA, 4-AAA and 4-FAA were 
purchased from Sigma–Aldrich (St Louis, MO, USA) and Toronto Research Chemicals (Ontario, 
Canada). 
HPLC-grade water was obtained by purifying demineralised water in a Milli-Q plus 
system from Millipore (Bedford, MA, USA). HPLC-grade methanol (MeOH), Sodium hydroxide 
>99% (NaOH), ammonia solution (25%), and formic acid (98–100%) were acquired from 
Scharlau (Barcelona, Spain). Leucine encephalin (used as the lock mass) was purchased from 
Sigma-Aldrich. 
 
2.2. Instrumentation 
UHPLC-QTOF MS 
A Waters Acquity UPLC system (Waters, Milford, MA, USA) was interfaced to a hybrid 
quadrupole-orthogonal acceleration-TOF mass spectrometer (XEVO G2 QTOF, Waters 
Micromass, Manchester, UK), using an orthogonal Z-spray-ESI interface operating in positive 
ion mode. The chromatographic separation was performed using an Acquity UPLC BEH C18 
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1.7-µm particle size analytical column 100  ×  2.1  mm (Waters) at a flow rate of 300  µL/min. The 
mobile phases used were A  =  H2O with 0.01% HCOOH and B  =  MeOH with 0.01% HCOOH. The 
initial percentage of B was 10%, which was linearly increased to 90% in 14  min, followed by a 2-
min isocratic period and, then, returned to initial conditions during 2  min in total run duration of 
18  min. Nitrogen was used as the drying gas and nebulizing gas. The gas flow was set at 
1200  L/h. TOF-MS resolution was approximately 25  000 at full width half maximum at m/z 556. 
MS data were acquired over an m/z range of 50–1200. A capillary voltage of 0.7  kV and cone 
voltage of 20  V were used. Collision gas was argon 99.995% (Praxair, Valencia, Spain). The 
interface temperature was set to 600°C and the source temperature to 120°C. The column 
temperature was set to 40°C. 
For MSE experiments, two acquisition functions with different collision energies were 
created. The low energy function (LE), selecting a collision energy of 4  eV, and the high energy 
(HE) function, with a collision energy ramp ranging from 15 to 40  eV in order to obtain a greater 
range of fragment ions. The LE and HE functions settings were for both a scan time of 0.3  s. 
Calibrations were automatically conducted from m/z 50 to 1200 with a 1:1 mixture of 
0.05-M NaOH:5% HCOOH diluted (1:25) with acetonitrile:water (80:20). For automated accurate 
mass measurement, the lock-spray probe was used, using as lockmass a solution of leucine 
enkephalin (2  µg/mL) in acetonitrile:water (50:50) at 0.1% HCOOH pumped at 20  µL/min. m/z 
556.2771 and m/z 278.1141 (corresponding to the protonated molecule of leucine enkephalin 
and to a fragment ion, respectively) were used for recalibrating the mass axis and ensuring a 
robust accurate mass measurement along time. 
 
UPLC-MS/MS 
For MS/MS experiments on the triple quadrupole (TQD) mass spectrometer, 
chromatographic separation was performed using an Acquity UPLC HSS T3 column (C18), 
1.8  µm, 100  ×  2.1  mm (Waters) at a flow rate of 300  µL/min. Mobile phase consisted of a 
water/methanol, both 0.1-mM NH4Ac and 0.01% HCOOH, gradient. The methanol percentage 
was changed linearly as follows: 0  min, 5%; 5  min, 90%; 6  min, 90%; 6.1  min; 5%. Analysis run 
time was 10  min. The sample injection volume was 20  µL. A TQD mass spectrometer with an 
orthogonal Z-spray-electrospray interface (Waters) was used. Drying gas as well as nebulising 
gas was nitrogen generated from pressurized air in a N2 LC–MS (Claind, Teknokroma, 
Barcelona, Spain). The cone gas and the desolvation gas flows were set at 60  L/h and 1200  L/h, 
respectively. For operation in MS/MS mode, collision gas was Argon 99.995% (Praxair, 
Valencia, Spain) with a performance of 2  ×  10  −  3 mbar in the T-Wave collision cell. A capillary 
voltage of 3.5  kV (positive ionization mode) and a cone voltage of 20  V were applied. The 
interface temperature was set to 500°C, and the source temperature to 120°C. A dwell time of 
0.01  s was selected. Selected SRM transitions were the following: 204.4  >  56.1 and 204.4  >  83.1 
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for 4-AA, 232.4  >  56.1 and 232.4  >  214.3 for 4-FAA and, 246.4  >  83.1 and 246.4  >  228.3 for 4-
AAA. 
 
2.3. Water samples 
Twenty-four effluent wastewaters extracts from the Spanish Mediterranean area, 
previously analysed by UHPLC-QqQ MS after being subjected to solid-phase extraction with 
Oasis HLB (60 mg),[18] were re-injected by UHPLC-(Q)TOF MS in order to investigate the 
possible presence of 4-AA and other metabolites of DIP. 
 
 
3. Results and discussion 
In a previous work, we developed a target method[18] based on UHPLC-MS/MS with 
TQD that was applied to the determination of 45 pharmaceuticals in water. As scientific 
literature shows, pharmaceutical metabolites have hardly been studied in environmental water 
and wastewater. Typically, only metabolites of those compounds classified as pro-drugs have 
been included in target methods.[19-21] This is the case of 4-AA (the main reported metabolite of 
DIP) and salicylic acid (the main metabolite of acetylsalicylic acid) that were also included in our 
previous work.[18] 4-AA was found in around 80% of the effluent wastewater samples analysed, 
with a maximum concentration of 2.8  µg/L. The two transitions selected, one for quantification 
(Q) 204  >  56, and the other for confirmation (q) 204  >  83, were observed in the samples and Q/q 
ratios were within the maximum deviations admitted. Under the chromatographic conditions 
employed, a poor chromatographic peak shape was observed in most of samples, presenting a 
clear shoulder, although the criteria used for confirmation of positives were accomplished. 
Therefore, the presence of 4-AA was assumed in the samples. 
However, the shoulder observed in the LC-MS/MS chromatograms for the two 
transitions monitored encouraged us to investigate the presence of this metabolite in more 
detail to discard a false positive. The same water samples extracts were subsequently analysed 
by UHPLC-(Q)TOF MS under MSE mode. With MSE experiments, both (de)protonated molecule 
and fragment ion data are enabled in a single acquisition, without the need of selecting the 
precursor ion, a notable difference with true MS/MS experiments.[8, 22, 23] 
Figure  1 shows LE and HE spectra of the 4-AA reference standard. The elemental 
composition for up to seven main fragments observed in the HE TOF MS spectrum was 
calculated, obtaining errors for accurate masses normally below 0.5  mDa in relation to the 
theoretical predicted exact masses. The structures suggested by MassFragment software are 
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also depicted, showing that the product ions previously selected for SRM transitions (m/z 56 
and 83) seem selective enough. 
 
 
 
Figure 1. LE and HE spectra of 4-aminoantipyrine (4-AA). Structures proposed by 
MassFragment software for fragment ions of this compound. 
 
 
In the samples analysed by QTOF MS, the narrow-window extracted ion 
chromatograms (nw-XIC) (20-mDa mass window)[24, 25] at the exact mass of 4-AA protonated 
molecule (m/z [M  +  H]+ 204.1137) were obtained from LE MS data. In several samples, two 
close peaks were observed, as shown in Fig.  2a. The chromatographic peak at 3.33  min was 
assigned, in principle, to 4-AA as the accurate mass (m/z 204.1132, Fig.  2b) differed −0.5  mDa 
from the theoretical mass of 4-AA, and its retention time did not exceed the maximum deviation 
of 2.5% typically allowed in LC-MS (reference retention time, 3.25  min).  However, the accurate 
mass of the second peak, at 3.45  min (m/z 204.1142, Fig.  2c) also differed only 0.5  mDa from 
the theoretical mass of 4-AA. When performing the nw-XICs at the expected exact masses of 4-
AA fragment ions (HE function), two chromatographic peaks were observed in each case at m/z 
159, 146, 104, 83 and 56, at both retention times (Fig.  2a). This fact strongly supported that the 
identity of the compound at 3.33  min was 4-AA. Obviously, the other peak at 3.45  min should 
correspond to a highly related compound. 
0.1 mDa
0.3 mDa
0.1 mDa
0.2 mDa
0.2 mDa
4-AA
0.3 mDa
-0.6 mDa
HE
LE 0.2 mDa
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However, the mass spectra of the compound eluting at 3.33  min presented two 
differentiated ions in the LE spectrum, at m/z values higher than the 4-AA protonated molecule. 
One of those was a highly abundant ion at m/z 232.1088 (Fig.  2b), and the other was a fragment 
ion at m/z 214.0982. The later was more visible in the HE spectrum (m/z 214.0976). The nw-
XICs at m/z 232.1088 for the LE and m/z 214.0976 for the HE function showed the presence of 
peaks at the same retention time with the same peak shape (Fig.  2a). Thus, it seemed that the 
accurate mass of the protonated molecule for this compound was 232.1088, and not 204.1132 
as initially believed. In addition, the m/z 214.0976 ion could be explained as a fragment derived 
from 232 due to a water loss. Obviously, the compound detected was not 4-AA, but it should be 
related with it as both shared up to six fragment ions. After searching in available database,[13] 
this compound was identified as 4-FAA. 
In a subsequent step, the reference standard was acquired and injected, confirming the 
identity of this compound. Hence, the presence of 4-AA was wrongly assigned when this 
sample was analysed by LC-MS/MS QqQ using the transitions 204  >  56 (Q) and 204  >  83 (q). It 
seems that 4-FAA produced an in-source fragment at m/z 204, which was afterwards isolated 
and fragmented in the collision cell to give the product ions at m/z 56 and 83. In addition, both 
compounds eluted in our chromatographic system at nearly the same retention time, making 
likely the reporting of 4-AA false positives. The occurrence of 4-FAA in wastewater has been 
previously investigated by Martínez-Bueno et al.[12] This metabolite was detected in 14 out of the 
19 samples analysed, at concentrations between 0.04 and 10  µg/L. 
Regarding the peak at 3.45  min, the LE spectrum presented an abundant ion at m/z 
246.1252 and the HE spectra at m/z 228.1137 (also corresponding to a water loss) (Fig.  2c). 
The nw-XICs at these masses showed the presence of a chromatographic peak at the same 
retention time (3.45  min) (Fig.  2a). Again, it seemed that this compound was closely related to 4-
AA, as both shared up to six fragment ions. After searching in available database,[13] this 
compound was identified as 4-AAA. As before, the reference standard was subsequently 
acquired and injected, confirming the identity of the compound. This metabolite has been also 
reported in wastewater at concentrations between 2 and 25  µg/L.[12] 
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Figure 2. Detection and identification of 4-formylaminoantipyrine (4-FAA) and 4-
acetylaminoantipyrine (4-AAA) in an effluent wastewater by UHPLC-QTOF under MSE mode: 
(a) XICs (20-mDa mass window) for [M  +  H]+ in LE function and for the main fragments in HE 
function; (b) LE and HE spectra of 4-FAA in the sample (chromatographic peak at 3.33  min); (c) 
LE and HE spectra of 4-AAA in the sample (chromatographic peak at 3.45  min). 
 
Thus, in this particular water sample, the metabolite detected was not 4-AA, but 4-AAA 
and 4-FAA. A false positive of 4-AA would have been reported if they were not 
chromatographically resolved. Under the chromatographic conditions employed in the UPLC-
QTOF MS, the three metabolites were roughly resolved as all eluted at close retention times. As 
illustrative example, Fig.  3 shows the UPLC-TOF MS chromatograms for a wastewater sample 
that was positive for the three metabolites, and where the presence of 4-AA could be 
unambiguously reported preventing its false identification. However, if no efficient 
chromatographic separation occurs for these metabolites, the presence of 4-AA cannot be 
ensured, even using HR in MS/MS mode, as derived from Müller et al.[26]  In that paper, 4-AA 
and 4-AAA perfectly co-eluted at 6.0  min. As 4-AA shares all its product ions with 4-AAA, the 
detection of the ion at m/z 204 might be related with an in-source fragment of 4-AAA and not 
with the presence of 4-AA. Therefore, to prevent such possibility, it is crucial an improvement in 
the chromatographic separation for minimising false identifications. 
 
HE
LE
204.1132
159.0918
146.0603
HE
LE
(a)
(b)
(c)
4-AAA
4-FAA
LE
LE
LE
HE
HE
HE
HE
HE
HE
HE
LE
LE
LE
HE
HE
HE
HE
HE
HE
HE
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Figure 3. UHPLC-QTOF MS XICs chromatograms and LE spectra for a wastewater sample 
containing 4-AA, 4-FAA and 4-AAA. 
 
On the basis of these results, the sample extracts previously analysed were injected 
again in the LC-MS/MS system, with a slight modification in the gradient slope and also 
considering the transitions for the two additional metabolites identified by TOF MS. Regarding 
the transitions selected for 4-AA, the cone voltage was reduced down to 20  V, to minimise in-
source fragmentation of the other metabolites. Figure  4 shows UHPLC-MS/MS chromatograms 
for a reference standard containing 4-AA, 4-AAA and 4-FAA, as well as for one of the positive 
wastewater samples reanalysed. As it can be seen, 4-AA eluted last, opposite to the results 
obtained when working with QTOF MS, where this compound eluted first. Additional 
experiments were performed in order to clarify if the change in elution order was due to the 
different column or to the different mobile phase additives. Both columns (HSS T3 and BEH 
C18) were tested using only 0.01% formic acid, or 0.01% formic acid plus 0.1-mM NH4Ac in the 
mobile phase. As shown in Fig.  5, the presence of 0.1-mM NH4Ac in the mobile phase seemed 
to be the responsible of this change. It is interesting to remark the higher retention of the 
analytes in the HSS T3 column (based on a C18 high strength silica stationary phase) than in the 
BEH C18 (based on ethylene bridged hybrid technology). 
In the particular example shown in Fig.  4B, the presence of 4-AA was in principle 
thought after being detected in the initial LC-MS/MS analysis. However, when this sample was 
re-analysed under the new conditions, only small traces of 4-AA were detected, well resolved 
from the in-source fragments produced by the presence of high concentrations of 4-AAA and 4-
FAA. 
4-AA
4-AAA
4-FAA
0.3 mDa
0.3 mDa
0.9 mDa
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Figure 4. UHPLC-MS/MS (QqQ) chromatograms of 4-AA, 4-FAA and 4-AAA obtained for (a) 
25-ng/mL reference standard and (b) wastewater sample containing 4-FAA and 4-AAA, after 
optimized chromatographic conditions. 
 
After re-analysing the water samples using different chromatographic conditions and 
selecting specific transitions for the two additional metabolites, it was feasible to discover the 
presence of metabolites other than 4-AA, initially selected as the only target analyte for DIP. 4-
AA was now detected in only 36% of samples analysed, whereas both 4-AAA and 4-FAA were 
found in around 90% of the samples. 
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Figure 5. UHPLC-QTOF MS XICs chromatograms for a reference standard containing 4-AA, 4-
FAA and 4-AAA (a) BEH C18 column, using only 0.01% formic acid in the mobile phase; (b) 
HSS T3 column, using only 0.01% formic acid in the mobile phase; (c) BEH C18, using both 
0.01% formic acid and 0.1-mM NH4Ac in the mobile phase. (d) HSS T3 column, using both 
0.01% formic acid and 0.1-mM NH4Ac in the mobile phase. 
 
The examples shown illustrate the importance of using full spectrum acquisition HRMS 
as well as suitable chromatographic separation to reduce the possibility of bi-isobaric co-eluting 
‘interferences’ when investigating metabolites. These interferences might be due to unexpected 
metabolites that share in-source fragment ions. Surely, the problems of false identifications 
might have been ignored if different chromatographic conditions would have been applied, 
and/or if the three metabolites would have been selected as target analytes in initial analysis. 
However, we would like to emphasize that false positives might occur in particular situations like 
that described in this article, where metabolites of pharmaceuticals, and surely of many other 
organic contaminants like pesticides, drugs of abuse, etc. are determined even using a powerful 
selective technique as LC-MS/MS under SRM mode. 
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4. Conclusions 
In this work, we illustrate the problems that may occur when investigating the presence 
of the pro-drug DIP, selecting the metabolite 4-AA as biomarker in the LC-MS/MS analysis of 
environmental water. The use of HRMS helped to discover that other metabolites of DIP (e.g. 4-
FAA and 4-AAA) produced 4-AA via in-source fragmentation, and consequently shared the 
same transitions. Under these circumstances, the chromatographic separation was crucial for 
avoiding the assignment of erroneous identifications. This situation might also occur with other 
contaminants when investigating metabolites or degradation products. The analyst has to take 
into account that metabolites of a given compound may share the same fragment ions 
complicating the right identification of the compound actually present in water. 
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